Literature DB >> 17171450

Collagenous colitis presenting after orthotopic liver transplantation for alpha-1-antitrypsin deficiency.

Kevin Halsey1, Mark Reichelderfer, Rod W Callicott, Darren C Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17171450     DOI： 10.1007/s10620-006-9414-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  20 in total

1.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors:  S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

2.  A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease.

Authors:  T R Riley; R E Schoen; R G Lee; J Rakela
Journal:  Am J Gastroenterol       Date:  1997-02       Impact factor: 10.864

3.  Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients.

Authors:  J Stephens; R Goldstein; J Crippin; B Husberg; M Holman; T A Gonwa; G Klintmalm
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 4.  Role of NF-kappaB in immune and inflammatory responses in the gut.

Authors:  M F Neurath; C Becker; K Barbulescu
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

5.  Collagenous colitis.

Authors:  T M Bayless; F M Giardiello; A Lazenby; J H Yardley
Journal:  Mayo Clin Proc       Date:  1987-08       Impact factor: 7.616

6.  The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation.

Authors:  A Shaked; J O Colonna; L Goldstein; R W Busuttil
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

7.  Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients.

Authors:  L Rostaing; O Puyoo; J Tkaczuk; C Peres; A Rouzaud; J M Cisterne; C de Preval; E Ohayon; D Durand; M Abbal
Journal:  Clin Transplant       Date:  1999-10       Impact factor: 2.863

Review 8.  Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis.

Authors:  G V Papatheodoridis; M Hamilton; P K Mistry; B Davidson; K Rolles; A K Burroughs
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

9.  Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998.

Authors:  M Olesen; S Eriksson; J Bohr; G Järnerot; C Tysk
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

10.  Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis.

Authors:  J S Gavaler; B Delemos; S H Belle; A E Heyl; R E Tarter; T E Starzl; C Gavaler; D H van Thiel
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.